Increased awareness of health workers

Oct 13, 2025 by recoveryshake.com 13 views

Rationality of the Use of Intravenous Preparations in Diarrhea Sufferers in Tk Hospital. II Putri Hijau Kesdam I Bukit Barisan

Introduction

Diarrhea is a serious health problem in developing countries, including Indonesia, with a high level of morbidity and mortality. In handling diarrhea, intravenous preparations are one of the most widely used drugs. However, the use of these preparations is not always rational, and this can lead to adverse effects and decreased treatment effectiveness. This study aims to evaluate the rationality of the use of intravenous preparations during diarrhea therapy, which includes appropriate aspects of the patient, precisely indicated, appropriate drugs, and exactly the dose.

Background

Diarrhea is a common disease that affects people of all ages, and it is a major public health problem in Indonesia. According to the World Health Organization (WHO), diarrhea is the second leading cause of death among children under the age of five, and it is also a significant cause of morbidity and mortality in adults. In Indonesia, diarrhea is a major cause of hospitalization, and it is estimated that over 1 million people are hospitalized due to diarrhea each year.

Intravenous preparations are widely used in the treatment of diarrhea, and they are often administered in hospitals and clinics. However, the use of these preparations is not always rational, and this can lead to adverse effects and decreased treatment effectiveness. In this study, we aim to evaluate the rationality of the use of intravenous preparations during diarrhea therapy, and to identify areas for improvement.

Methodology

This descriptive retrospective study was conducted at the Medical Record Installation of Tk. II Putri Hijau Kesdam I Bukit Barisan Medan. The criteria used are inpatients who experience diarrhea due to bacterial infections during the period January to December 2018. A total of 90 patients were included in the study, and their medical records were reviewed to evaluate the use of intravenous preparations.

Results

From the results of the study, we found that there were some inaccuracies in the use of drugs. Specifically, overdose occurred in Ceftriaxone in 12 cases and in ciprofloxacin in 9 cases. In addition, we also found adverse drug interactions, such as a combination of ringer lactate and ceftriaxone which caused incompatibility in 17 cases, as well as a combination of ciprofloxacin and ondansetron which could increase heart rhythm in 9 cases.

Discussion

The results of this study indicate that the use of intravenous preparations in diarrhea therapy is not always rational. Overdose and adverse drug interactions are common problems that can lead to adverse effects and decreased treatment effectiveness. These findings are consistent with previous studies that have reported similar problems with the use of intravenous preparations in diarrhea therapy.

The use of intravenous preparations in diarrhea therapy is a complex issue that requires careful consideration of several factors, including the patient's medical history, the severity of the disease, and the potential risks and benefits of treatment. In this study, we found that the use of Ceftriaxone and ciprofloxacin was not in accordance with the right dose criteria, and that interactions that occurred during therapy indicated a potential risk for patients.

Conclusion

In conclusion, this study found that the use of intravenous preparations in diarrhea therapy is not always rational. Overdose and adverse drug interactions are common problems that can lead to adverse effects and decreased treatment effectiveness. These findings highlight the need for increased awareness of health workers about the use of drugs that are rational and safe, in order to minimize risk and ensure the effectiveness of treatment.

Recommendations

Based on the findings of this study, we recommend the following:

Increased awareness of health workers: Health workers need to be aware of the potential risks and benefits of treatment, and they need to use drugs that are rational and safe.
Improved monitoring and evaluation: Hospitals need to conduct periodic training for health workers regarding guidelines for the correct drug use, and they need to establish a strict monitoring and evaluation system for drug use.
Use of information technology: The use of information technology in medical records can help monitor treatment and detect mismatch in drug use.
Further research: Further research is needed to explore other factors that influence the use of intravenous preparations in diarrhea therapy, as well as finding more innovative solutions to improve the efficiency of treatment and patient safety.

Future Directions

In the future, further research is needed to explore other factors that influence the use of intravenous preparations in diarrhea therapy, as well as finding more innovative solutions to improve the efficiency of treatment and patient safety. Some potential areas for future research include:

Development of new guidelines: New guidelines for the use of intravenous preparations in diarrhea therapy need to be developed, and they need to be based on the latest evidence.
Improved monitoring and evaluation: Hospitals need to establish a strict monitoring and evaluation system for drug use, and they need to use information technology to monitor treatment and detect mismatch in drug use.
Training for health workers: Health workers need to be trained on the use of intravenous preparations in diarrhea therapy, and they need to be aware of the potential risks and benefits of treatment.
Patient education: Patients need to be educated on the use of intravenous preparations in diarrhea therapy, and they need to be aware of the potential risks and benefits of treatment.

Limitations

This study has several limitations, including:

Small sample size: The sample size of this study was small, and it may not be representative of the larger population.
Retrospective design: This study was retrospective, and it may not capture the full range of factors that influence the use of intravenous preparations in diarrhea therapy.
Limited data: The data used in this study were limited, and they may not capture the full range of factors that influence the use of intravenous preparations in diarrhea therapy.

Conclusion

Q: What is the purpose of this study?

A: The purpose of this study is to evaluate the rationality of the use of intravenous preparations during diarrhea therapy, which includes appropriate aspects of the patient, precisely indicated, appropriate drugs, and exactly the dose.

Q: What is the significance of this study?

A: This study is significant because it highlights the need for increased awareness of health workers about the use of drugs that are rational and safe, in order to minimize risk and ensure the effectiveness of treatment.

Q: What are the common problems with the use of intravenous preparations in diarrhea therapy?

A: The common problems with the use of intravenous preparations in diarrhea therapy include overdose and adverse drug interactions.

Q: What are the potential risks of using intravenous preparations in diarrhea therapy?

A: The potential risks of using intravenous preparations in diarrhea therapy include adverse effects and decreased treatment effectiveness.

Q: What are the recommendations for improving the use of intravenous preparations in diarrhea therapy?

A: The recommendations for improving the use of intravenous preparations in diarrhea therapy include increased awareness of health workers, improved monitoring and evaluation, use of information technology, and further research.

Q: What are the limitations of this study?

A: The limitations of this study include small sample size, retrospective design, and limited data.

Q: What are the future directions for this study?

A: The future directions for this study include development of new guidelines, improved monitoring and evaluation, training for health workers, and patient education.

Q: What are the implications of this study for healthcare providers?

A: The implications of this study for healthcare providers are that they need to be aware of the potential risks and benefits of treatment, and they need to use drugs that are rational and safe.

Q: What are the implications of this study for patients?

A: The implications of this study for patients are that they need to be educated on the use of intravenous preparations in diarrhea therapy, and they need to be aware of the potential risks and benefits of treatment.

Q: What are the implications of this study for healthcare policy?

A: The implications of this study for healthcare policy are that there is a need for increased awareness of health workers about the use of drugs that are rational and safe, and there is a need for improved monitoring and evaluation of drug use.

Q: What are the implications of this study for future research?

A: The implications of this study for future research are that there is a need for further research to explore other factors that influence the use of intravenous preparations in diarrhea therapy, and there is a need for finding more innovative solutions to improve the efficiency of treatment and patient safety.

Q: What are the implications of this study for healthcare education?

A: The implications of this study for healthcare education are that there is a need for increased awareness of health workers about the use of drugs that are rational and safe, and there is a need for improved training for health workers on the use of intravenous preparations in diarrhea therapy.

Q: What are the implications of this study for healthcare quality improvement?

A: The implications of this study for healthcare quality improvement are that there is a need for improved monitoring and evaluation of drug use, and there is a need for finding more innovative solutions to improve the efficiency of treatment and patient safety.

Q: What are the implications of this study for healthcare safety?

A: The implications of this study for healthcare safety are that there is a need for increased awareness of health workers about the use of drugs that are rational and safe, and there is a need for improved monitoring and evaluation of drug use to prevent adverse effects.

Q: What are the implications of this study for healthcare economics?

A: The implications of this study for healthcare economics are that there is a need for improved monitoring and evaluation of drug use to prevent waste and reduce costs, and there is a need for finding more innovative solutions to improve the efficiency of treatment and patient safety.

Q: What are the implications of this study for healthcare policy makers?

A: The implications of this study for healthcare policy makers are that there is a need for increased awareness of health workers about the use of drugs that are rational and safe, and there is a need for improved monitoring and evaluation of drug use to inform policy decisions.

Q: What are the implications of this study for healthcare administrators?

A: The implications of this study for healthcare administrators are that there is a need for improved monitoring and evaluation of drug use to inform administrative decisions, and there is a need for finding more innovative solutions to improve the efficiency of treatment and patient safety.

Q: What are the implications of this study for healthcare researchers?

A: The implications of this study for healthcare researchers are that there is a need for further research to explore other factors that influence the use of intravenous preparations in diarrhea therapy, and there is a need for finding more innovative solutions to improve the efficiency of treatment and patient safety.